Aravive Reports Positive Data Supporting Relationship Between AVB-500 Levels, Anti-Tumor Activity and Progression Free Survival in Women with Ovarian Cancer


You May Also Like

Targovax ASA: New member of the board of directors

Oslo, Norway, 30 November 2017 - Targovax ASA (OSE: TRVX), a clinical stage company ...

MDxHealth Reports Financial Year 2016 Results

NEWS RELEASE   REGULATED INFORMATION  INSIDE INFORMATION  Record revenue of $30 million, up 70% from ...